Literature DB >> 27781958

Metalloproteinase 2 and 9 Activity Increase in Epicardial Adipose Tissue of Patients with Coronary Artery Disease.

Verónica Miksztowicz, Celina Morales, Magalí Barchuk, Graciela López, Ricardo Póveda, Ricardo Gelpi, Laura Schreier, Miguel Rubio, Gabriela Berg1.   

Abstract

BACKGROUND: Epicardial adipose tissue (EAT) is a visceral adipose tissue (AT) surrounding and infiltrating myocardium and coronary arteries. Increased EAT may represent a chronic inflammatory injury and a link with coronary artery disease (CAD). Metalloproteinases (MMPs) are involved in expansion of AT.
OBJECTIVE: To evaluate MMP-2 and -9 behaviour in EAT from CAD patients.
METHODS: In EAT and subcutaneous AT (SAT) from patients undergoing coronary artery bypass graft (CABG, n=26) or valve replacement (No CABG, n=18), MMP-2 and -9 activity and localization, inflammatory cells and vascular endothelial growth factor (VEGF) levels were determined.
RESULTS: In EAT from CABG, MMP-2 and -9 activity was increased compared with No CABG (p=0.041 and p=0.027, respectively) and compared with SAT (p=0.005 and p=0.048, respectively). In CABG patients EAT showed higher infiltration of macrophages and T lymphocytes than SAT (p=0.01 and p=0.002, respectively). In No CABG patients no sign of cellular retention was observed in EAT or SAT. Vascular density was higher in EAT from CABG than No CABG (p=0.015) and it was directly correlated with MMP-2 (p=0.006) and MMP-9 (p=0.02). VEGF levels in EAT were directly associated with MMP-2 (p=0.016).
CONCLUSION: In EAT from CABG patients the increase of MMP-2 and -9 activity and the presence of inflammatory cells would be partially responsible for extracellular matrix (ECM) remodeling and major vascular density necessary for EAT expansion. Improved knowledge of EAT behaviour may allow to identify new therapeutic targets for the treatment of CAD. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.org.

Entities:  

Keywords:  Epicardial adipose tissue; coronary arteryzzm321990bypass graft; coronary artery disease; metalloproteinases; subcutaneous adipose tissue

Mesh:

Substances:

Year:  2017        PMID: 27781958     DOI: 10.2174/1570161114666161024124244

Source DB:  PubMed          Journal:  Curr Vasc Pharmacol        ISSN: 1570-1611            Impact factor:   2.719


  8 in total

Review 1.  Microenvironment of Immune Cells Within the Visceral Adipose Tissue Sensu Lato vs. Epicardial Adipose Tissue: What Do We Know?

Authors:  Martin Klein; Ivan Varga
Journal:  Inflammation       Date:  2018-08       Impact factor: 4.092

Review 2.  Mechanisms linking adipose tissue inflammation to cardiac hypertrophy and fibrosis.

Authors:  Sarah R Anthony; Adrienne R Guarnieri; Anamarie Gozdiff; Robert N Helsley; Albert Phillip Owens; Michael Tranter
Journal:  Clin Sci (Lond)       Date:  2019-11-29       Impact factor: 6.124

3.  A potential key mechanism in ascending aortic aneurysm development: Detection of a linear relationship between MMP-14/TIMP-2 ratio and active MMP-2.

Authors:  Ramona Schmitt; Anke Tscheuschler; Philipp Laschinski; Xenia Uffelmann; Philipp Discher; Jana Fuchs; Maximilian Kreibich; Remi Peyronnet; Fabian A Kari
Journal:  PLoS One       Date:  2019-02-22       Impact factor: 3.240

Review 4.  Behavior of Metalloproteinases in Adipose Tissue, Liver and Arterial Wall: An Update of Extracellular Matrix Remodeling.

Authors:  Gabriela Berg; Magalí Barchuk; Verónica Miksztowicz
Journal:  Cells       Date:  2019-02-14       Impact factor: 6.600

5.  PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation.

Authors:  Elena Dozio; Massimiliano Ruscica; Elena Vianello; Chiara Macchi; Clementina Sitzia; Gerd Schmitz; Lorenza Tacchini; Massimiliano M Corsi Romanelli
Journal:  Mediators Inflamm       Date:  2020-06-04       Impact factor: 4.711

6.  The Effect of Liraglutide on Epicardial Adipose Tissue in Type 2 Diabetes.

Authors:  Na Zhao; Xiaoying Wang; Yongbo Wang; Junjie Yao; Chunhong Shi; Jianling Du; Ran Bai
Journal:  J Diabetes Res       Date:  2021-11-16       Impact factor: 4.011

Review 7.  Recent Developments in Extracellular Matrix Remodeling for Fat Grafting.

Authors:  Xin Bi; Ye Li; Ziqing Dong; Jing Zhao; Weizi Wu; Jialiang Zou; Lingling Guo; Feng Lu; Jianhua Gao
Journal:  Front Cell Dev Biol       Date:  2021-12-16

8.  Atherosclerosis Pathways are Activated in Pericoronary Adipose Tissue of Patients with Coronary Artery Disease.

Authors:  Michał Konwerski; Agnieszka Gromadka; Adam Arendarczyk; Marta Koblowska; Roksana Iwanicka-Nowicka; Radosław Wilimski; Paweł Czub; Krzysztof Jerzy Filipiak; Piotr Hendzel; Piotr Zielenkiewicz; Grzegorz Opolski; Aleksandra Gąsecka; Tomasz Mazurek
Journal:  J Inflamm Res       Date:  2021-10-20
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.